EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN BIOLOGICS NAIVE RA PATIENTS - PMS FOR INVESTIGATING SUCCESS IN ACHIEVING CLINICAL AND FUNCTIONAL REMISSION AND SUSTAINING EFFICACY WITH TOCILIZUMAB IN BIOLOGICS-NAIVE RA PATIENTS (FIRST BIO) STUDY

被引：0

作者：

Mimori, T. ^{[1
]}

Atsumi, T. ^{[2
]}

Harigai, M. ^{[3
]}

Nishimoto, N. ^{[4
]}

Sumida, T. ^{[5
]}

Takeuchi, T. ^{[6
]}

Tanaka, Y. ^{[7
]}

Yamanaka, H. ^{[8
]}

Nakasone, A. ^{[9
]}

Takagi, N. ^{[9
]}

Ishiguro, N. ^{[10
]}

机构：

[1] Kyoto Univ, Kyoto, Japan

[2] Hokkaido Univ, Sapporo, Hokkaido, Japan

[3] Tokyo Med & Dent Univ, Tokyo, Japan

[4] Tokyo Med Univ, Tokyo, Japan

[5] Univ Tsukuba, Tsukuba, Ibaraki, Japan

[6] Keio Univ, Tokyo, Japan

[7] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan

[8] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan

[9] Chugai Pharmaceut, Tokyo, Japan

[10] Nagoya Univ Hosp, Nagoya, Aichi, Japan

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷

关键词：

D O I：

10.1136/annrheumdis-2015-eular.1829

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0211

引用

页码：733 / 733

页数：1

共 17 条

[11] LONG-TERM EFFICACY AND SAFETY OF TOCILIZUMAB (TCZ) MONOTHERAPY IN PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA) PREVIOUSLY METHOTREXATE (MTX) NAIVE OR MTX FREE FOR 6 MONTHS PRIOR TO STUDY START
Jones, G.
Sebba, A.
Anisfeld, A.
Devenport, J.
Bernasconi, C.
Smart, D.
Galindez, D.
Mpofu, C.
Gomez-Reino, J.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 457 - 458
[12] Long-Term Efficacy and Safety of Tocilizumab (TCZ) Monotherapy in Patients (PTS) with Rheumatoid Arthritis (RA) Previously Methotrexate (MTX) Naive or MTX Free for 6 Months Prior to Study Start
Khraishi, Majed
Sebba, Anthony
Anisfeld, Andrew
Devenport, Jenny
Bernasconi, Corrado
Smart, Devi
Galindez, Daniel
Mpofu, Chiedzo
Gomez-Reino, Juan
Jones, Graeme
JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1469 - 1469
[13] BASELINE PROCALCITONIN (PCT) LEVEL AS A PREDICTIVE MARKER FOR CLINICAL REMISSION (DAS28-ESR, CDAI) AT 52 WEEKS IN BIOLOGIC NAIVE RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED BY TOCILIZUMAB (TCZ); A SINGLE CENTER RETROSPECTIVE STUDY
Tsuji, S.
Yura, A.
Katayama, M.
Watanabe, A.
Teshigawara, S.
Yoshimura, M.
Tanaka, E. K.
Harada, Y.
Kagawa, K.
Katada, Y.
Matsushita, M.
Ohshima, S.
Hashimoto, J.
Saeki, Y.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 956 - 957
[14] Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)
Izumi, Keisuke
Kaneko, Yuko
Hashizume, Misato
Yoshimoto, Keiko
Takeuchi, Tsutomu
PLOS ONE, 2015, 10 (12):
[15] Pharmacokinetic Similarity and Comparative Pharmacodynamics, Safety, Efficacy, and Immunogenicity of DRL_RI Versus Reference Rituximab in Biologics-Naive Patients with Moderate-to-Severe Rheumatoid Arthritis: A Double-Blind, Randomized, Three-Arm Study
Haridas, Vikram Muralidhar
Katta, Rahul
Nalawade, Ajit
Kharkar, Sandeep
Zhdan, Vyacheslav
Garmish, Olena
Lopez-Lazaro, Luis
Batra, Sonica Sachdeva
Kankanwadi, Suresh
BIODRUGS, 2020, 34 (02) : 183 - 196
[16] Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study) (vol 10, e0145468, 2015)
Izumi, Keisuke
Kaneko, Yuko
Hashizume, Misato
Yoshimoto, Keiko
Takeuchi, Tsutomu
PLOS ONE, 2016, 11 (03):
[17] A CLINICAL STUDY TO INVESTIGATE PHARMACOKINETICS (PK), PHARMACODYNAMICS (PD), EFFICACY, AND SAFETY OF TOCILIZUMAB (TCZ) AFTER SUBCUTANEOUS (SC) ADMINISTRATION WEEKLY (QW) OR EVERY TWO WEEKS (Q2W) IN PATIENTS (pts) WITH RHEUMATOID ARTHRITIS (RA).
Zhang, X.
Chen, Y.
Fettner, S.
Anzures-Cabrera, J.
Gott, T.
Grimsey, P.
Unsworth, A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S117 - S117

← 1 2 →